Cochlear Investor Relations Material
Latest events
H1 2024
Cochlear
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Cochlear Limited
Access all reports
Cochlear Limited is a developer, manufacturer and marketer of implantable hearing solutions for adults and children worldwide. It provides in-the-ear devices that restore functional hearing to people with sensorineural, or ‘brain-based’, hearing loss; a condition caused by damage to the inner ear or auditory nerve. Cochlear products are sold through OEM partnerships with medical device companies, who integrate them into their products and distribute them through their own sales networks to physicians worldwide. Customers for these products include audiologists and surgeons involved in cochlear implant surgery, as well as hospitals, government health agencies and other users of off-the-shelf implanted components such as hearing aid dispensers.
Key slides for Cochlear Limited
H1 2024
Cochlear Limited
H1 2024
Cochlear Limited
Latest articles
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Companies That Had Their IPO in 2022: War, Inflation and Interest Rates
The stock market and IPO landscape in 2022 was marked by inflationary pressures, rate hikes, and war that heavily impacted the market sentiment.
15 Apr 2024
Ticker symbol
Country
🇦🇺 Australia